In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of psychiatric …, 2014 - Elsevier
Background The administration of statins seems to be a promising new avenue in the
treatment of patients suffering from major depressive disorder (MDD), though patients …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of Psychiatric …, 2014 - infona.pl
The administration of statins seems to be a promising new avenue in the treatment of
patients suffering from major depressive disorder (MDD), though patients suffering from …

[引用][C] In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe …

M HAGHIGHI, S KHODAKARAMI… - Journal of …, 2014 - pascal-francis.inist.fr
In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of
depression and blood lipid values in patients suffering from severe major depressive …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of psychiatric …, 2014 - folia.unifr.ch
METHODS A total of 60 patients suffering from MDD (mean age: 32.25 years; 53% males)
received a standard medication of 40 mg/d citalopram. Next, patients were randomly …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of psychiatric …, 2014 - safetylit.org
BACKGROUND: The administration of statins seems to be a promising new avenue in the
treatment of patients suffering from major depressive disorder (MDD), though patients …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - 2014 - pubmed.ncbi.nlm.nih.gov
Background The administration of statins seems to be a promising new avenue in the
treatment of patients suffering from major depressive disorder (MDD), though patients …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of psychiatric …, 2014 - sonar.ch
METHODS A total of 60 patients suffering from MDD (mean age: 32.25 years; 53% males)
received a standard medication of 40 mg/d citalopram. Next, patients were randomly …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of Psychiatric …, 2014 - europepmc.org
Background The administration of statins seems to be a promising new avenue in the
treatment of patients suffering from major depressive disorder (MDD), though patients …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of Psychiatric …, 2014 - elibrary.ru
Background: The administration of statins seems to be a promising new avenue in the
treatment of patients suffering from major depressive disorder (MDD), though patients …

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major …

M Haghighi, S Khodakarami, L Jahangard… - Journal of Psychiatric …, 2014 - edoc.unibas.ch
The administration of statins seems to be a promising new avenue in the treatment of
patients suffering from major depressive disorder (MDD), though patients suffering from …